Annual report pursuant to Section 13 and 15(d)

REDEEMABLE NON CONTROLLING INTEREST (Narrative) (Details)

v3.10.0.1
REDEEMABLE NON CONTROLLING INTEREST (Narrative) (Details)
€ in Thousands
1 Months Ended 12 Months Ended
Jun. 13, 2018
USD ($)
Jun. 13, 2018
EUR (€)
Jan. 16, 2019
USD ($)
Jun. 28, 2018
USD ($)
Nov. 15, 2017
USD ($)
Nov. 15, 2017
EUR (€)
Nov. 30, 2018
USD ($)
shares
Nov. 30, 2017
USD ($)
Debt Conversion, Converted Instrument, Amount             $ 8,056,000  
Due to Related Parties, Current             0 $ 116,000
Non-controlling interests             299,000 0
GPP receivable             $ 6,600,000 0
SFPI [Member]                
Noncontrolling Interest, Increase from Sale of Parent Equity Interest         $ 5,900,000 € 5,000    
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners         16.70%      
Debt Conversion, Converted Instrument, Amount         $ 1,180,000 1,070    
Payments for subscription amounts $ 2,300,000 € 1,900     2,300,000 € 2,000    
Debt Conversion, Converted Instrument, Rate             0.85%  
Equity interest, convertible, conversion price         $ 6.24      
Non-controlling interests             $ 5,800,000 $ 3,600,000
GPP [Member]                
Noncontrolling Interest, Amount Represented by Preferred Stock       $ 378,000        
Noncontrolling Interest, Increase from Sale of Parent Equity Interest       $ 25,000,000        
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners       37.80%        
Non-controlling interests             18,400  
Noncontrolling Interest, Increase from Sale of Parent Equity Interest, subject to certain contingencies       $ 13,200,000        
Proceeds from Divestiture of Interest in Subsidiaries and Affiliates       11,800,000        
Proceeds used to reimburse the investors for their fees and expenses       1,500,000        
Net Proceeds from Divestiture of Interest in Subsidiaries and Affiliates       10,300,000        
Follow-up payments       6,600,000        
Spinoff threshold       $ 50,000,000        
Description of Stockholders Agreement       The Stockholders’ Agreement further provides that GPP-II is entitled, at any time, to convert its share capital in Masthercell Global for the Company’s common stock in an amount equal to the lesser of (a)(i) the fair market value of GPP-II’s shares of Masthercell Global Preferred Stock to be exchanged, divided by (ii) the average closing price per share of the Company’s Common Stock during the thirty day period ending on the date that GPP-II provides the exchange notice (the “Exchange Price”) and (b)(i) the fair market value of GPP-II’s shares of Masthercell Global Preferred Stock to be exchanged assuming a value of Masthercell Global equal to three and a half (3.5) times the revenue of Masthercell Global during the last twelve (12) complete calendar months immediately prior to the exchange divided by (ii) the Exchange Price; provided, that in no event will (A) the Exchange Price be less than a price per share that would result in Orgenesis Inc having an enterprise value of less than $250 million and (B) the maximum number of shares of the Company’s Common Stock to be issued shall not exceed 2,704,247 shares, unless the Company obtains shareholder approval for the issuance of such greater amount of shares of the Company in accordance with the rules and regulations of the Nasdaq Stock Market.        
Description of advisory services agreement       Great Point and Masthercell Global entered into an advisory services agreement pursuant to which Great Point is to provide management services to Masthercell Global for which Great Point will be compensated at an annual base compensation equal to the greater of (i) $250 thousand per each 12 month period or (ii) 5% of the EBITDA for such 12 month period, payable in arrears in quarterly installments; provided, that these payments will (A) begin to accrue immediately, but shall not be paid in cash to Great Point until such time as Masthercell Global generates EBITDA of at least $2 million for any 12 month period or the sale of or change in control of Masthercell Global, and (B) shall not exceed an aggregate annual amount of $0.5 million. Such compensation accrues but is not owed to Great Point until the earlier of (i) Masthercell Global generating EBITDA of at least $2 million for any 12 months period following the date of the agreement or (ii) a Sale of the Company or Change of Control of the Company (as both terms are defined therein).        
GPP receivable             $ 6,600,000  
Proceeds from collection of receivables     $ 6,600,000          
MaSTherCell [Member]                
Shares of subsidiary held | shares             622,000  
Equity Method Investment, Ownership Percentage             62.20%